Arcturus Therapeutics Holdings Inc (ARCT), a global messenger RNA medicine company which made significant strides in advancing its pipeline in 2023, expects to launch its first product in Japan this year.
Kostaive, a self-amplifying mRNA COVID-19 vaccine for primary vaccination and booster for adults 18 years and older, developed by Arcturus in partnership with CSL, is expected to be launched in Japan this year. The vaccine was approved by Japan's Ministry of Health, Labor and Welfare last November.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.